GB1406345A - Pharmaceutical preparations comprising substituted resorcinols - Google Patents

Pharmaceutical preparations comprising substituted resorcinols

Info

Publication number
GB1406345A
GB1406345A GB4749673A GB4749673A GB1406345A GB 1406345 A GB1406345 A GB 1406345A GB 4749673 A GB4749673 A GB 4749673A GB 4749673 A GB4749673 A GB 4749673A GB 1406345 A GB1406345 A GB 1406345A
Authority
GB
United Kingdom
Prior art keywords
group
hydrogen atom
pharmaceutical preparations
oct
substituted resorcinols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4749673A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THIEMANN CHEM PHARM FAB
Original Assignee
THIEMANN CHEM PHARM FAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THIEMANN CHEM PHARM FAB filed Critical THIEMANN CHEM PHARM FAB
Publication of GB1406345A publication Critical patent/GB1406345A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/86—Ketones containing a keto group bound to a six-membered aromatic ring containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Abstract

1406345 Compositions containing resorcinols CHEM. PHARMAZ FABRIK DR. HERMANN THIEMANN GmbH 11 Oct 1973 [13 Oct 1972] 47496/73 Heading A5B [Also in Division C2] A pharmaceutical composition comprises a resorcinol of the general formula wherein X represents an oxygen atom or an -NH group, R<SP>1</SP> represents a hydrogen atom or a methyl group, R<SP>2</SP> represents a hydrogen atom or a methyl, alkoxycarbonyl or group, R<SP>3</SP> represents the group wherein R<SP>1</SP> and R<SP>2</SP> have the above-mentioned meaning, R<SP>4</SP> represents a hydrogen atom, R<SP>5</SP> represents a hydrogen atom or the group R<SP>3</SP>, R<SP>6</SP> represents a hydrogen atom or a hydroxyl group or R<SP>3</SP> and R<SP>4</SP> together denote the radical wherein R<SP>1</SP> and R<SP>2</SP> have the above meaning, or a physiologically tolerable salt thereof.
GB4749673A 1972-10-13 1973-10-11 Pharmaceutical preparations comprising substituted resorcinols Expired GB1406345A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722250343 DE2250343A1 (en) 1972-10-13 1972-10-13 4,6-DISUBSTITUTED RESORCINE COMPOUNDS

Publications (1)

Publication Number Publication Date
GB1406345A true GB1406345A (en) 1975-09-17

Family

ID=5859002

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4749673A Expired GB1406345A (en) 1972-10-13 1973-10-11 Pharmaceutical preparations comprising substituted resorcinols

Country Status (5)

Country Link
BE (1) BE805838A (en)
DE (1) DE2250343A1 (en)
FR (1) FR2202692B1 (en)
GB (1) GB1406345A (en)
NL (2) NL160167C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000300A1 (en) * 2003-06-27 2005-01-06 Vernalis (Cambridge) Limited Substituted 5-membered ring compounds and their use
WO2010121963A1 (en) 2009-04-21 2010-10-28 Nerviano Medical Sciences S.R.L. Resorcinol derivatives as hsp90 inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929345T2 (en) 1998-08-07 2006-09-21 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville SUBSTITUTED ISOXAL DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000300A1 (en) * 2003-06-27 2005-01-06 Vernalis (Cambridge) Limited Substituted 5-membered ring compounds and their use
US7728016B2 (en) 2003-06-27 2010-06-01 Vernalis (Cambridge) Limited Substituted 5-membered ring compounds and their use
WO2010121963A1 (en) 2009-04-21 2010-10-28 Nerviano Medical Sciences S.R.L. Resorcinol derivatives as hsp90 inhibitors
US8993556B2 (en) 2009-04-21 2015-03-31 Nerviano Medical Sciences S.R.L. Resorcinol derivatives as HSP90 inhibitors

Also Published As

Publication number Publication date
NL160167C (en) 1979-10-15
NL160167B (en) 1979-05-15
BE805838A (en) 1974-02-01
NL7610797A (en) 1977-01-31
FR2202692A1 (en) 1974-05-10
FR2202692B1 (en) 1977-03-11
DE2250343A1 (en) 1974-04-18
NL7313957A (en) 1974-04-16

Similar Documents

Publication Publication Date Title
ES8307794A1 (en) Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them.
IL49204A (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
ES463632A1 (en) Piperidine derivatives
DK365488A (en) NEW BENSIMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND A PHARMACEUTICAL PREPARATION CONTAINING THEM
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1418208A (en) Pharmaceutical compositions
ES8106892A1 (en) 4-Aryloxy- and 4-arylthio-3-phenylpiperidine derivatives, a process for the preparation of such compounds and pharmaceutical compositions containing them.
ES476106A1 (en) 4-Spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances.
GB1507356A (en) Denture cleanser
SE8405588D0 (en) NEW COMPOUNDS
ES433860A1 (en) 3-(4{40 -Alkoxy-benzoyl)-1,2,2-trimethylcyclopentane-carboxylic acids, methods of use and compositions containing such compounds
GB1406345A (en) Pharmaceutical preparations comprising substituted resorcinols
ES434431A1 (en) 1&#39;-substituted xanthene-9-spiro-4&#39;-piperidine derivatives
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
ES483662A1 (en) N-Phenylindoline derivatives, and pharmaceutical compositions containing them
IL44266A0 (en) Novel substituted 2-phenylamino-imidazolines-(2) and their salts,their preparation and pharmaceutical compositions containing them
ES8203334A1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use.
GB1223816A (en) New amine compounds and methods for their production
GB1413454A (en) 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof
GB1498857A (en) Antidepressant composition
GB1401590A (en) Dentifrices
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
GB1424611A (en) Pharmaceutical compositions
ES8304923A1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it.
ES8105284A1 (en) Indoline derivatives, their production and pharmaceutical composition containing them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee